Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy
Table 2
Prevalence of different complications and LVEF following ICD insertion in a one-year follow-up divided into three equal parts.
Variables
First 4-month follow-up period
Second 4-month follow-up period
Third 4-month follow-up period
Total 1-year follow-up period
ICD implantation-related complications
Pneumothorax
1 (1.4%)
0 (0%)
0 (0%)
1 (1.4%)
Perforation
1 (1.4%)
0 (0%)
0 (0%)
1 (1.4%)
Upper limb DVT
1 (1.4%)
1 (1.4%)
0 (0%)
2 (2.8%)
ICD infection
1 (1.4%)
0 (0%)
0 (0%)
1 (1.4%)
Lead failure
0 (0%)
1 (1.4%)
0 (0%)
1 (1.4%)
Total
4 (5.6%)
2 (2.8%)
0 (0%)
6 (8.5%)
ICD not implantation-related complications
Inappropriate shock
1 (1.4%)
3 (4.2%)
4 (5.6%)
8 (11.3%)
Total complications
5 (7.0%)
5 (7.0%)
4 (5.6%)
LVEF, %
52.2 ± 4.7
51.8 ± 4.4
51.7 ± 4.8
All of the data of the complications are expressed as the frequency and percentage for different complications of ICD insertion. LVEF is reported in the mean ± SD. DVT, deep vein thrombosis; ICD, implantable cardioverter defibrillator; LVEF, left ventricular ejection fraction.
